Charcot-Marie-Tooth Disease Dominant Intermediate II

Charcot-Marie-Tooth disease dominant intermediate II is a rare inherited nerve disease. It damages the peripheral nerves, which are the long nerves that carry signals between the brain, spinal cord, muscles and skin. Because the problem is in the nerves, muscles in the feet, legs, hands and sometimes arms slowly become weak and thin, and feeling (sensation) is reduced. Doctors call it “dominant intermediate” because it is usually passed in an autosomal dominant way (one changed gene from one parent is enough) and nerve tests show speeds that are “in-between” the usual slow (demyelinating) and normal (axonal) types. NCBI+1

Charcot-Marie-Tooth disease dominant intermediate II (often grouped within dominant intermediate CMT, or DI-CMT) is a rare inherited nerve disease. It affects the peripheral nerves, which carry signals between the spinal cord, muscles and skin. In DI-CMT, nerve conduction speeds are “intermediate” between the very slow speeds seen in demyelinating forms and the near-normal speeds seen in axonal forms, and the condition is passed in an autosomal dominant way (one changed copy of the gene is enough to cause disease).Charcot-Marie-Tooth Association+2Charcot-Marie-Tooth News+2

Over time, people develop weakness and wasting in the feet, legs, hands and sometimes forearms. They may have high-arched feet, hammer toes, problems with balance, falls, and burning or electric-like nerve pain. At present there is no cure and no approved “disease-modifying” drug that stops or reverses nerve damage in any CMT subtype. Treatment focuses on symptom control, rehabilitation and preventing complications, using a team of neurologists, physiotherapists, occupational therapists, orthotists, pain specialists and surgeons when needed.PMC+2nhs.uk+2

Another names

Charcot-Marie-Tooth disease dominant intermediate II is part of the big Charcot-Marie-Tooth (CMT) group. Doctors and books may use several other names for very similar or overlapping conditions. NCBI+1

  1. Charcot-Marie-Tooth disease (CMT)
    This is the main family name. It covers many related inherited nerve diseases that all cause slowly progressive weakness and numbness in the limbs. Dominant intermediate II is one member of this family. NCBI+1

  2. Hereditary motor and sensory neuropathy (HMSN)
    This is an older name. “Hereditary” means inherited, “motor” means movement, and “sensory” means feeling. “Neuropathy” means nerve problem. Doctors still sometimes use HMSN as another name for CMT diseases. NCBI+1

  3. Peroneal muscular atrophy
    This name came from the fact that muscles near the peroneal nerve (on the outer side of the lower leg) become thin and weak first. The term is less exact, but you may see it in older papers and reports. NCBI+1

  4. Autosomal dominant intermediate Charcot-Marie-Tooth disease (DI-CMT)
    This is a group name. It means the disease is autosomal dominant and nerve speeds are intermediate. Dominant intermediate II is one of the autosomal dominant intermediate CMT types. PMC+1

  5. CMT dominant intermediate B/C/D/E/F (CMTDIB, CMTDIC, etc.)
    In the medical literature, several lettered subtypes (B, C, D, E, F) are described inside dominant intermediate CMT. These names are based on the gene that is changed and the family in which the type was first found. Your doctor may sometimes use such a code plus a number or Roman numeral (like II) to describe the exact subtype. National Organization for Rare Disorders+3NCBI+3National Organization for Rare Disorders+3

Types

Charcot-Marie-Tooth disease is divided into main types depending on how the nerve is damaged and how fast the signals travel in nerve tests. NCBI+1

  1. Demyelinating CMT (often called CMT1)
    In this type, the myelin sheath, which is the insulating cover around the nerve, is mainly damaged. Nerve conduction is very slow. Muscles become weak, and reflexes are reduced. This type is different from dominant intermediate II, but the symptoms can overlap. NCBI+1

  2. Axonal CMT (often called CMT2)
    In this type, the axon, which is the inner “wire” of the nerve, is mainly damaged. Nerve conduction speed can be near normal, but the signal size is low. Some doctors may have used the term “type II” for axonal forms, so the number II in your disease name can be related to this history. NCBI+1

  3. Intermediate CMT (dominant and recessive forms)
    In intermediate CMT, nerve conduction speed is between the very slow demyelinating range and the normal axonal range. Both the myelin and the axon can be affected. Dominant intermediate II belongs to this group. PMC+1

  4. Autosomal dominant intermediate CMT (DI-CMT)
    This subgroup has autosomal dominant inheritance. Many genes can cause it, including MPZ, INF2, DNM2, YARS, GNB4, NEFL and MFN2. The exact subtype label (including “II”) depends on which gene is changed and how the disease was first described in a family. PMC+1

  5. Autosomal recessive intermediate CMT (RI-CMT)
    This subgroup needs two changed copies of a gene (one from each parent). It has different gene causes, such as GDAP1, KARS and PLEKHG5. It is not the same as dominant intermediate II, but doctors compare it when they study intermediate-type CMT. PMC+1

Causes

All known main causes of dominant intermediate CMT, including type II, are genetic. This means the problem comes from changes (mutations) in certain genes that are important for nerve structure and function. NCBI+2PMC+2

  1. Autosomal dominant inheritance from an affected parent
    The most common cause is getting one changed copy of a disease gene from a parent who also has CMT. Each child has a 50% chance to inherit the changed gene and the disease. This pattern is called autosomal dominant. NCBI+1

  2. DNM2 gene mutation (dynamin-2)
    Changes in the DNM2 gene are a well-known cause of dominant intermediate CMT, especially the B subtype. Dynamin-2 is a protein involved in how cells move membranes and transport material. When it does not work well, long nerves in the legs and arms are damaged. PMC+1

  3. MPZ gene mutation (myelin protein zero)
    MPZ makes a key protein in the myelin sheath. Some MPZ mutations lead to intermediate nerve conduction speeds, neither very slow nor normal. This pattern can fit dominant intermediate forms like type II. PMC+1

  4. INF2 gene mutation (inverted formin-2)
    INF2 helps shape the cell skeleton and actin filaments. Certain INF2 mutations cause dominant intermediate CMT, sometimes with kidney disease. The gene change makes nerves fragile and easier to damage. PMC+1

  5. YARS gene mutation (tyrosyl-tRNA synthetase)
    YARS is important for making proteins inside cells. Some YARS mutations disturb protein building in nerve cells and cause dominant intermediate CMT in affected families. PMC+1

  6. GNB4 gene mutation (G protein subunit beta-4)
    Mutations in GNB4 have been clearly linked to autosomal dominant intermediate CMT. This gene helps control cell signalling. When changed, it can disturb nerve signalling and cause weakness and numbness. PMC+1

  7. NEFL gene mutation (neurofilament light chain)
    NEFL forms part of the internal skeleton of nerve axons. Some NEFL mutations give an intermediate conduction pattern that matches dominant intermediate CMT types. Axons become unstable and slowly degenerate. PMC+1

  8. MFN2 gene mutation (mitofusin-2)
    MFN2 helps maintain healthy mitochondria in nerve cells. Certain MFN2 mutations cause CMT with intermediate conduction properties. Damaged mitochondria cannot support the long nerves well, leading to weakness and sensory loss. PMC+1

  9. GJB1 gene mutation with intermediate pattern
    GJB1 (also called Cx32) usually causes X-linked CMT, but in some patients the nerve speeds fall in the intermediate range. This shows that different genes can give a similar “intermediate” pattern of damage. PMC+1

  10. Other rare gene mutations in the CMT gene list
    New CMT genes are still being discovered. Some of them can give an intermediate pattern and may be grouped under dominant intermediate forms, including type II, depending on family studies. NCBI+1

  11. De novo mutation (new gene change in the child)
    Sometimes neither parent has CMT, but a new mutation happens in the egg or sperm or early embryo. The child is the first in the family with dominant intermediate CMT. That child can then pass the changed gene to his or her own children. NCBI+1

  12. Mutations that damage myelin structure
    Some mutations mainly harm the myelin sheath. In dominant intermediate types, myelin damage is present but not as severe as in classic demyelinating CMT. This mixed effect helps explain the intermediate conduction speed. NCBI+1

  13. Mutations that damage the axon
    Other mutations mainly harm the axon. In intermediate CMT, axon damage combines with some myelin changes, so the speed and size of nerve signals are both affected. NCBI+1

  14. Mutations affecting mitochondrial function in nerves
    Genes like MFN2 show that problems with mitochondria can cause CMT. When mitochondria cannot produce enough energy, long peripheral nerves struggle to survive and work properly, leading to distal weakness. NCBI+1

  15. Mutations affecting cytoskeleton and axonal transport
    Genes such as NEFL and INF2 disturb the inner scaffolding and transport systems of nerves. This leads to “dying-back” of nerve endings, especially in the feet and hands, over many years. PMC+1

  16. Mutations affecting vesicle trafficking and endocytosis
    DNM2 is an example of a gene that controls vesicle movement and membrane recycling. When this process fails, nerve cells cannot manage their membranes correctly, and axons slowly degenerate. PMC+1

  17. Mutations affecting cell signalling pathways
    GNB4 is part of cell signalling. Abnormal signals may change how nerve cells respond to stress and injury, causing chronic neuropathy. This is another mechanism behind dominant intermediate CMT. PMC+1

  18. Mutations affecting protein translation in nerves
    YARS mutations show that even basic protein-making machinery can be a cause. If proteins are not made correctly, nerve cells cannot maintain their long fibres, and neuropathy slowly appears. PMC+1

  19. Combination of genetic mutation and modifier genes
    The main disease gene is the primary cause, but other genes can modify how severe the disease is. Some family members with the same main mutation have milder or more severe disease because of these “modifier” genes. NCBI+1

  20. Unknown gene mutation not yet identified
    In some patients with a clear dominant intermediate pattern, genetic tests still cannot find the exact gene. In these cases, the cause is likely a mutation in a gene that has not yet been discovered or is not routinely tested. NCBI+1

Symptoms

The symptoms of dominant intermediate II are similar to other CMT forms. They usually start in the feet and legs and slowly move upward, and later can affect the hands. NCBI+2Mayo Clinic+2

  1. Weakness in the feet and ankles
    The first sign is often trouble lifting the front of the foot. The person may trip easily or feel that the ankle is weak, especially when walking on uneven ground. Mayo Clinic+1

  2. Foot drop and “steppage” gait
    Because the foot does not lift well, the person may raise the knee higher than normal to avoid dragging the toes. This is called a steppage gait and is common in CMT. NCBI+1

  3. Muscle wasting in the lower legs (“inverted champagne bottle” legs)
    Over time, the muscles below the knee become thin, while the upper legs stay more normal. This gives a shape sometimes described as “inverted champagne bottle” legs. NCBI+1

  4. High arches and hammertoes
    The foot muscles become imbalanced. Some muscles pull harder than others. This can cause high-arched feet (pes cavus) and toes that curl downward (hammertoes). Mayo Clinic+1

  5. Weakness in the hands and fingers
    Later in the disease, the small muscles of the hands can become weak. This makes tasks like buttoning clothes, writing, or opening jars more difficult. NCBI+1

  6. Numbness or reduced feeling in feet and hands
    Many people lose some sense of touch, pain, or temperature in their feet and, later, hands. They may not feel small injuries or may feel like they are wearing thin socks or gloves. NCBI+2Mayo Clinic+2

  7. Tingling or burning sensations (paresthesias)
    Some patients feel pins-and-needles, tingling, or burning pain in the feet or hands. These feelings come from irritated or damaged sensory nerves. NCBI+1

  8. Loss of tendon reflexes
    The doctor may notice that ankle and knee reflexes are reduced or absent. The patient may not notice this as a symptom, but it is an important clinical sign. NCBI+1

  9. Poor balance, especially in the dark
    Because of weak muscles and reduced position sense, standing or walking with eyes closed can be hard. Some people sway or fall more easily in the dark or in the shower. NCBI+1

  10. Fatigue with walking or standing
    Long walks or standing for a long time can make the legs feel very tired. Weak muscles and inefficient gait require more effort for the same activity. Mayo Clinic+1

  11. Hand clumsiness
    Fine tasks such as typing, sewing, or using small tools may feel clumsy. This comes from both weakness and reduced sensation in the fingers. NCBI+1

  12. Foot and ankle pain
    Deformities and abnormal walking put stress on joints and ligaments. Some people develop chronic foot or ankle pain, especially if they do not use proper shoes or braces. Mayo Clinic+1

  13. Leg cramps
    Muscles that are weak and overworked can cramp, especially at night. Cramps can disturb sleep and cause discomfort. NCBI+1

  14. Scoliosis or other skeletal changes in some patients
    Long-term muscle imbalance can sometimes lead to problems in the spine, such as scoliosis, or changes in joints, although this is not present in everyone. NCBI+1

  15. Slow but progressive course over many years
    Symptoms usually start in childhood, teenage years, or early adulthood and slowly progress over decades. The speed of change is often slow, but disability can increase over time. NCBI+2Mayo Clinic+2

Diagnostic tests

Doctors diagnose dominant intermediate II by combining the story, physical examination, nerve tests, and genetic tests. They also use other tests to rule out different causes of neuropathy. NCBI+2PMC+2

Physical exam tests

  1. General neurological examination
    The doctor checks strength, sensation, reflexes, muscle bulk, and coordination in all four limbs. In dominant intermediate CMT, they often find weakness and wasting in the feet and lower legs, reduced reflexes, and reduced sensation in a stocking-glove pattern. NCBI+1

  2. Gait observation
    The doctor watches how the patient walks. They look for foot drop, steppage gait, wide base, and difficulty with heel and toe walking. These patterns help show that a chronic peripheral neuropathy like CMT is present. NCBI+1

  3. Inspection of feet and hands
    The clinician looks for high arches, hammertoes, calluses, and deformities, and for wasting of the small hand muscles. These visible changes support a diagnosis of long-standing hereditary neuropathy. Mayo Clinic+1

  4. Balance and Romberg testing
    The patient is asked to stand with feet together, first with eyes open and then closed. Increased sway or falling with eyes closed suggests sensory loss from peripheral nerves, which fits CMT. NCBI+1

Manual tests

  1. Manual muscle testing (MRC grading)
    The doctor grades muscle strength in many muscles using hand resistance. Distal muscles in the feet and hands are usually weaker than proximal muscles. This pattern is typical of hereditary neuropathy. NCBI+1

  2. Manual tendon reflex testing with a hammer
    Using a reflex hammer, the doctor checks ankle, knee, and upper-limb reflexes. Reduced or absent ankle reflexes are common in CMT and support the diagnosis. NCBI+1

  3. Sensory testing with cotton, pin and tuning fork
    Light touch, pin-prick and vibration are tested manually. Loss of vibration in the toes and reduced feeling to light touch or pin show sensory nerve involvement. NCBI+1

  4. Functional tests such as heel-toe walking and stair climbing
    The patient is asked to walk on heels, then toes, and to climb steps. Difficulty with these tasks points to distal weakness and helps measure disease severity over time. NCBI+1

Lab and pathological tests

  1. Blood tests to rule out acquired neuropathies
    Basic blood tests (such as blood sugar, vitamin B12, thyroid function, kidney and liver tests) are done to exclude diabetes, vitamin lack, and other causes. Normal results support a hereditary cause like CMT. NCBI+1

  2. Genetic panel testing for CMT genes
    Modern genetic panels can test many CMT-related genes at once, including DNM2, MPZ, INF2, YARS, GNB4, NEFL, MFN2 and others. Finding a pathogenic mutation confirms the specific CMT subtype. NCBI+1

  3. Targeted single-gene testing
    If the family history or nerve conduction pattern strongly suggests one gene (for example DNM2 for some dominant intermediate types), a focused test of that gene can be done. This is sometimes used when a panel is not available. PMC+1

  4. Next-generation sequencing (NGS) or whole exome sequencing
    If standard panels are negative, broader DNA sequencing may be used to look for rare or new mutations. This is especially helpful in intermediate types, where many different genes may be involved. NCBI+1

  5. Nerve biopsy (sural nerve biopsy)
    In uncertain cases, a small piece of a sensory nerve near the ankle can be removed and examined under a microscope. The biopsy shows changes in myelin and axons that match hereditary neuropathy, though it is used less often now because genetic tests are better. NCBI+1

  6. Muscle biopsy
    Occasionally, a muscle sample is examined to show patterns of chronic denervation and reinnervation. This supports a long-standing neuropathy but usually is not needed when the clinical picture and nerve tests are clear. NCBI+1

Electrodiagnostic tests

  1. Nerve conduction studies (NCS)
    Electrodes are placed on the skin over nerves. Small shocks are used to measure how fast and how strong the nerve signals are. In dominant intermediate CMT, speeds are in an intermediate range, not as slow as classic demyelinating CMT and not normal. This pattern is key for the diagnosis. NCBI+2PMC+2

  2. Electromyography (EMG)
    A thin needle electrode is placed into muscles to record electrical activity. EMG shows signs of chronic denervation and reinnervation, meaning that nerves have been slowly damaged and muscles are trying to adapt. NCBI+1

  3. F-wave and late response studies
    Special parts of nerve conduction tests look at signals traveling up and down long nerve segments. They can show subtle slowing or block in motor nerves and provide more detail about the pattern of neuropathy. NCBI+1

Imaging tests

  1. Foot and ankle X-rays
    Standard X-rays of the feet and ankles can show high arches, hammertoes, and other deformities. They help surgeons plan braces or surgery if needed but do not directly show the nerve problem. NCBI+1

  2. Spine X-rays or MRI if scoliosis or back pain is present
    If there is concern for spinal curvature or other bone problems, images of the spine are taken. These help separate skeletal issues from the nerve disease but are not required in every patient. NCBI+1

  3. Ultrasound or MRI of peripheral nerves (in selected cases)
    In some centers, ultrasound or MRI is used to look at the size and structure of peripheral nerves. They may show thickened or abnormal nerves in CMT. These tests are still more common in research than in daily practice. NCBI+1

Non-pharmacological treatments (therapies and other approaches)

  1. Individualized physiotherapy program
    A long-term physiotherapy program is a central non-drug treatment for dominant intermediate CMT. The physiotherapist designs gentle, regular exercises to keep muscles working for as long as possible, reduce stiffness, and protect joints. Sessions usually include stretching, strengthening and balance training that are adapted to your weakness pattern and fatigue level. The purpose is to slow loss of function, reduce contractures, and help you stay independent. The main mechanism is repeated, safe movement that maintains muscle fibres, trains the nervous system, and keeps joints moving in a healthy range.Physiopedia+2PMC+2

  2. Stretching and range-of-motion exercises
    Daily stretching of ankles, knees, hips, wrists and fingers helps prevent muscles and tendons from shortening. When muscles around weak joints tighten, fixed deformities and pain can appear. Guided stretches, done slowly and held for several seconds, keep soft tissues long and flexible. The purpose is to delay or avoid contractures and to make walking and hand use easier. The mechanism is simple: gentle, repeated lengthening of muscles and tendons signals the body to preserve length and reduces stiffness in the joint capsule.

  3. Strengthening exercises with low resistance
    Light strengthening exercises target muscles that still have some power. In CMT, heavy resistance can worsen fatigue and does not rebuild severely damaged nerves, so resistance is usually low and repetitions are moderate. The purpose is to preserve remaining strength, improve posture and support weak joints without over-straining them. The mechanism is that active muscle use improves neuromuscular efficiency and helps surrounding muscles partially compensate for weaker ones.

  4. Balance and coordination training
    Because CMT damages sensory fibres that tell the brain where your joints are, balance becomes poor. Balance training uses standing on different surfaces, single-leg stance with support, and simple stepping tasks. The aim is to reduce falls and improve confidence when walking. The mechanism involves retraining visual and vestibular systems to help compensate for weak or numb ankles and feet, and teaching safer movement strategies.

  5. Aerobic conditioning (low-impact cardio)
    Low-impact aerobic exercise, such as cycling on a stationary bike, swimming, or walking in a pool, can safely improve heart and lung fitness in many people with CMT. The purpose is to increase endurance, reduce fatigue, and support overall health, including mood. The mechanism is better oxygen delivery, improved cardiovascular efficiency, and release of endorphins, all while putting less stress on weak ankles and feet than running or jumping.

  6. Occupational therapy for hands and daily activities
    Occupational therapists help with fine hand weakness, fatigue, and difficulty doing school, work or self-care tasks. They may suggest adapted pens, button hooks, special kitchen tools, or computer access devices. The purpose is to keep you independent in daily life. The mechanism is task modification and assistive devices that reduce the force needed from small hand muscles and redistribute effort to stronger joints.

  7. Hand therapy and splinting
    Targeted hand therapy can include specific exercises for grip, pinch and finger coordination, along with custom splints for wrists or thumbs. The purpose is to support weak joints, improve function, and reduce pain or joint collapse. Splints work mechanically by holding joints in safer positions, improving the angle at which tendons work and preventing deformities from progressing.

  8. Orthoses and bracing (AFOs and shoe inserts)
    Ankle-foot orthoses (AFOs), insoles and custom shoes support weak ankle and foot muscles, correct foot drop, and improve gait. They can be made of lightweight plastic or carbon fibre and tailored to your leg shape and walking pattern. The purpose is to reduce tripping, improve stability and reduce energy cost when walking. The mechanism is external support that limits excessive ankle motion, lifts the toes during swing phase, and redistributes pressure on the soles.Charcot-Marie-Tooth Association+2The Foundation for Peripheral Neuropathy+2

  9. Walking aids (canes, crutches, rollators)
    Some people benefit from using a cane, forearm crutch or rollator, especially on uneven ground or during long walks. The purpose is to reduce falls and conserve energy. These aids work by adding extra points of contact with the ground, widening your base of support and allowing your arms to carry part of your body weight, which helps compensate for leg weakness and sensory loss.

  10. Home and school safety modifications
    Simple changes at home and school can lower the risk of accidents. Examples include removing loose rugs, improving lighting, using handrails on stairs and arranging furniture to create clear walking paths. The purpose is to reduce trips and falls. The mechanism is environmental: when there are fewer obstacles, your impaired balance and sensation have less chance to cause injury.

  11. Pain psychology and cognitive-behavioral therapy (CBT)
    Chronic neuropathic pain is common in CMT and can affect mood and sleep. Working with a psychologist trained in pain management helps people learn coping skills, relaxation, and thought patterns that reduce suffering. The purpose is not to “deny” pain but to reduce its impact on daily life. The mechanism is changing how the brain processes pain signals, reducing stress hormones, and improving sleep and activity patterns.Charcot-Marie-Tooth Association+1

  12. Energy conservation and pacing strategies
    Because muscles are weak and nerves are damaged, people with CMT often tire easily. Occupational therapists teach pacing, planning breaks, and prioritizing tasks so that important activities can be done when energy is highest. The purpose is to reduce exhaustion and overuse pain. The mechanism is better distribution of limited physical resources across the day and week.

  13. Weight management and healthy lifestyle coaching
    Extra body weight makes walking, standing and climbing stairs harder and increases joint strain. Nutrition counselling and gentle exercise plans help maintain a healthy weight. The purpose is to reduce mechanical load on weak muscles and joints and lower risks like diabetes that can further damage nerves. The mechanism is a combination of fewer calories, better food quality, and increased activity within safe limits.

  14. Respiratory and posture training (in advanced cases)
    A small subset of people with CMT may develop scoliosis or mild breathing muscle weakness. Breathing exercises, postural training and, rarely, non-invasive ventilation at night can help. The purpose is to maintain good lung function and comfort. The mechanism is improved chest expansion, stronger respiratory muscles and more efficient breathing.

  15. Vocational and educational support
    Career and school guidance helps people choose paths that match their physical abilities and allow needed accommodations. The purpose is to protect long-term participation in work or study. The mechanism is early planning, assistive technology, and legal accommodations that reduce physical strain and fatigue.

  16. Genetic counselling for patients and families
    Because DI-CMT is autosomal dominant, each child of an affected person has a 50% chance of inheriting the variant. Genetic counsellors explain inheritance, testing options and family planning choices. The purpose is to support informed decisions and reduce anxiety. The mechanism is clear information and emotional support, not change of the gene itself.MedlinePlus+1

  17. Peer support groups and patient organisations
    Joining CMT support groups, online communities, or organisations like CMT advocacy groups connects people with others facing similar challenges. The purpose is to reduce isolation, share coping tips, and give emotional support. The mechanism is social connection, shared knowledge and advocacy, which can also improve access to specialists and research.

  18. Mind–body therapies (yoga, tai chi, relaxation)
    Gentle yoga or tai chi, under guidance and adapted for balance problems, may help flexibility, mood and body awareness. Relaxation techniques like deep breathing or meditation can reduce stress and pain perception. The purpose is to enhance quality of life, not to cure nerve damage. The mechanism involves calming the nervous system and improving muscle control and breathing.

  19. Foot care by podiatry
    Regular visits to a podiatrist help manage calluses, nail problems and pressure points in high-arched or deformed feet. The purpose is to prevent skin breakdown and ulcers, which are more likely when sensation is reduced. The mechanism is careful inspection and treatment plus footwear advice, which reduces abnormal pressure and friction.

  20. Regular multidisciplinary follow-up
    Seeing a neurologist, rehabilitation team and orthopedic or foot specialist at regular intervals allows early detection of changes and timely adjustments in braces, exercises or pain management. The purpose is to stay ahead of complications, not to wait for crises. The mechanism is proactive monitoring and small, early interventions that keep function as stable as possible over time.PMC+1


Drug treatments

Important safety note: No medicine is currently approved specifically to cure or slow Charcot-Marie-Tooth disease, including dominant intermediate II. Medicines mainly treat neuropathic pain, muscle cramps, mood and sleep. Many of the drugs below are approved by the U.S. FDA for other neuropathic conditions like diabetic peripheral neuropathy or post-herpetic neuralgia and are used off-label in CMT after careful discussion with a doctor.Charcot-Marie-Tooth Association+2Springer+2

  1. Pregabalin (Lyrica / Lyrica CR)
    Pregabalin is an anti-seizure medicine widely used for nerve pain. It binds to calcium channels in nerve cells and helps reduce the release of excitatory neurotransmitters, which calms over-active pain pathways. The FDA has approved pregabalin for several neuropathic pain conditions and fibromyalgia, not specifically CMT.PMC+3FDA Access Data+3FDA Access Data+3 Typical dosing for adults is divided two or three times a day and adjusted by kidney function, but exact doses must be chosen by a doctor because side effects like dizziness, sleepiness, weight gain and swelling can occur.

  2. Gabapentin (Neurontin)
    Gabapentin is another anti-seizure drug often used for neuropathic pain. It also binds to voltage-gated calcium channels and reduces abnormal firing in damaged nerves, which can lower burning and shooting pain. FDA approvals include seizures and certain neuralgias, but doctors sometimes use it off-label for CMT pain.U.S. Food and Drug Administration+1 Doses are usually slowly increased to limit dizziness and tiredness, and only a prescriber can set a safe schedule.

  3. Duloxetine (Cymbalta and others)
    Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant that is FDA-approved for diabetic neuropathic pain, fibromyalgia and depression.PMC+2hhs.texas.gov+2 It boosts levels of serotonin and norepinephrine in pain-modulating pathways of the brain and spinal cord, which can reduce pain intensity and improve mood. One or two daily doses are common, but doctors must adjust for liver health and watch for nausea, dry mouth and changes in mood.

  4. Amitriptyline
    Amitriptyline is a tricyclic antidepressant that has long been used at low doses to treat chronic neuropathic pain. It blocks reuptake of serotonin and norepinephrine and also acts on sodium channels, which dampens pain signals. Guidelines list it as a first-line or early option for neuropathic pain.Springer+1 It is usually taken once at night because it can cause drowsiness, dry mouth and constipation; only a doctor can choose a safe starting dose.

  5. Nortriptyline
    Nortriptyline is another tricyclic antidepressant similar to amitriptyline but sometimes better tolerated. It also enhances descending pain-inhibiting pathways in the spinal cord. Doctors may choose it if amitriptyline is too sedating. Dosing is slowly increased under supervision to balance pain relief against side effects like dizziness and heart rhythm changes, so self-adjusting is unsafe.

  6. Venlafaxine
    Venlafaxine is an SNRI antidepressant that can also help neuropathic pain by boosting serotonin and norepinephrine levels. It is sometimes used when duloxetine is not tolerated. It is taken once or twice a day, and the doctor must monitor blood pressure and mood, as it can raise blood pressure or cause withdrawal symptoms if stopped suddenly.

  7. Carbamazepine or Oxcarbazepine
    These anti-seizure drugs block voltage-gated sodium channels and can reduce certain sharp, electric-shock pains, especially trigeminal neuralgia. Some doctors may use them in specific neuropathic pain patterns. They require blood tests for sodium levels and liver function, and doses must be carefully increased because of potential dizziness, allergic rashes and low sodium.

  8. Lamotrigine
    Lamotrigine is another anti-seizure medicine that stabilises nerve membranes and may be tried in neuropathic pain that does not respond to first-line agents. It must be started at very low doses and increased very slowly because of a rare but serious skin reaction (Stevens–Johnson syndrome). For this reason, any rash while on lamotrigine needs urgent medical attention, and only specialists should manage dosing.

  9. Topical lidocaine patches
    Lidocaine 5% medicated patches can be applied over a painful area of skin, often for localised burning pain. Lidocaine blocks sodium channels in sensory nerves in the skin, which reduces firing. Used correctly, systemic absorption is low, and side effects are usually mild skin irritation. A doctor or pharmacist must explain maximum number of patches and how long they can safely be worn each day.

  10. Capsaicin cream or high-dose patches
    Capsaicin is the active compound in chili peppers and, in high concentrations, can temporarily reduce pain by overstimulating and then desensitising pain fibres. Low-strength creams can be applied several times a day, while high-dose patches are applied in clinic under supervision. It can cause strong burning at first, so medical guidance is essential.

  11. Non-steroidal anti-inflammatory drugs (NSAIDs)
    Drugs like ibuprofen or naproxen do not treat nerve damage itself, but they can help muscle and joint pain that comes from abnormal walking patterns or foot deformities. They work by blocking cyclo-oxygenase enzymes and reducing inflammatory prostaglandins. Because they can irritate the stomach and affect kidneys and heart, a doctor should set dose and duration, especially if used often.

  12. Paracetamol / acetaminophen
    Paracetamol is often the first simple pain reliever for mild aches. It does not have strong anti-inflammatory effects, but it is generally gentler on the stomach. Its exact mechanism is still being studied, but it likely acts within the central nervous system to reduce pain. Overdoses can harm the liver, so total daily doses must stay within recommended limits set by a doctor.

  13. Tramadol (with care)
    Tramadol is a weak opioid that also affects serotonin and norepinephrine reuptake. It may be used short-term for severe pain that does not respond to other medicines. Because it can cause dependence, drowsiness, nausea, and rarely seizures, guidelines usually place it as a second-line or later option and recommend close medical supervision.

  14. Baclofen
    Baclofen is a muscle relaxant that acts on GABA receptors in the spinal cord to reduce muscle spasm and stiffness. Some people with CMT have painful cramps that respond to low doses. It can cause weakness and sleepiness, so doctors start with small doses and adjust slowly, and it must not be stopped suddenly after long use.

  15. Tizanidine
    Tizanidine is another muscle relaxant that acts on alpha-2 adrenergic receptors and can reduce spasticity and cramps. It is sometimes used when baclofen is not suitable. Because it can lower blood pressure and affect the liver, monitoring by a doctor is essential, and doses are carefully titrated.

  16. Clonazepam (for restless legs and anxiety)
    Clonazepam is a benzodiazepine that has anti-anxiety and muscle-relaxing effects. In some cases it is used for restless legs or sleep disruption linked to neuropathy. It acts on GABA receptors to calm nerve activity. Because of dependence and sedation risks, doctors generally prefer non-benzodiazepine options first and keep doses as low and short-term as possible.

  17. Selective serotonin reuptake inhibitors (SSRIs)
    SSRIs like sertraline may not directly treat neuropathic pain, but they can help depression and anxiety that commonly accompany chronic illness. Better mood can indirectly improve pain coping and quality of life. Doses and choice of SSRI depend on age, other medicines and side effect profile, and they must be started and stopped under medical supervision.

  18. Sleep medicines (short-term use only)
    In severe pain, short courses of sleep aids may be used to break a cycle of insomnia and fatigue. These could be non-benzodiazepine “Z-drugs” or low-dose sedating antidepressants. Because of risks of dependence and falls, doctors use them carefully and focus on sleep hygiene and pain control first.

  19. Topical NSAID gels
    Gels containing diclofenac or similar agents can be rubbed onto painful joints or tendons. They deliver anti-inflammatory drug locally with less systemic exposure. They are useful for mild joint pain from abnormal gait but do not affect nerve damage. Skin irritation and rare systemic effects are still possible, so label instructions must be followed.

  20. Off-label combinations under specialist care
    Sometimes specialists combine two different neuropathic pain drugs, such as pregabalin plus duloxetine, when a single medicine is not enough. Studies in other neuropathies suggest combinations can help some patients but also increase side effect risk.resed.es+3SciSpace+3ScienceDirect+3 Only a pain specialist or neurologist should design such regimens, adjusting doses slowly and monitoring mood, breathing, and organ function.


Dietary molecular supplements

Evidence for supplements in CMT is limited, and none of these is a cure. They may help if there is a real deficiency or as supportive care. Always talk to your doctor before taking any supplement, especially if you already take prescription medicines.

  1. Vitamin B12 (cobalamin)
    Vitamin B12 is essential for myelin, the insulating covering of nerves. Deficiency can cause neuropathy that looks similar to CMT, so doctors often check levels. Supplementing deficiency helps nerves work properly again, but it does not reverse inherited CMT. Doses depend on blood levels and can be injections or tablets; giving more than needed does not create “super nerves,” so treatment is guided by tests.

  2. Vitamin B1 (thiamine)
    Thiamine is vital for energy production in nerve cells. Severe lack can cause painful neuropathy. Doctors may suggest thiamine if diet is poor, alcohol intake is high in adults, or levels are low. Typical supplements are once daily tablets, but dosing is individualized. It supports normal nerve metabolism but does not fix the faulty gene in CMT.

  3. Vitamin B6 (pyridoxine – with caution)
    Vitamin B6 is involved in many nerve pathways, and mild deficiency is sometimes corrected with supplements. However, very high long-term doses of B6 can actually cause neuropathy. Therefore, if a supplement is used, the dose must stay within doctor-recommended limits and based on labs, not on guesswork.

  4. Folate (vitamin B9)
    Folate works with B12 in DNA synthesis and cell repair, including cells that form myelin. Correcting folate deficiency can improve overall health and may support nerve function. Doses are usually low to moderate and guided by blood tests, especially in people with poor nutrition or certain medications. It is not a treatment for the genetic cause of CMT.

  5. Alpha-lipoic acid
    Alpha-lipoic acid is an antioxidant used in some countries for diabetic neuropathy. It may reduce oxidative stress in nerve tissue. Some small studies show reduced burning pain in neuropathies, but evidence in CMT is limited. Oral doses vary widely and can affect blood sugar, so a doctor should decide if it’s appropriate.

  6. Omega-3 fatty acids (fish oil)
    Omega-3 fatty acids have anti-inflammatory effects and support cell membrane health. They may benefit general cardiovascular health and possibly nerve cell membranes. Typical dosing is one to several capsules per day, but they can thin the blood slightly, so doctors must check for interactions with other medicines and bleeding risks.

  7. Vitamin D
    Vitamin D is important for bone and muscle health. Low levels can worsen muscle weakness and increase fall risk. Replacing deficiency helps bones stay strong, especially when feet and ankles are already unstable. Doses are based on blood levels and age, and too much vitamin D can harm kidneys, so testing and guidance are important.

  8. Magnesium
    Magnesium supports muscle and nerve function and may help some people with cramps. However, high doses can cause diarrhoea and, in kidney disease, even heart rhythm problems. Doctors may recommend a moderate supplement if blood magnesium is low or diet is poor, but they will adjust the dose carefully.

  9. Acetyl-L-carnitine
    Acetyl-L-carnitine is involved in mitochondrial energy production, and small studies in other neuropathies suggest it might reduce pain or support nerve repair. Evidence is not strong for CMT, and doses vary. Because it can interact with thyroid function and other medicines, any use should be discussed with a specialist.

  10. Coenzyme Q10 (CoQ10)
    CoQ10 is another mitochondrial co-factor sometimes used to support energy metabolism. In primary mitochondrial diseases it can help, but in CMT evidence is limited. Low to moderate daily doses are usually well tolerated but can interact with blood thinners, so medical advice is needed.


Regenerative, immunity-booster and stem-cell-related drugs

Right now, there are no approved immune-booster or stem-cell drugs that are proven to regenerate nerves in Charcot-Marie-Tooth disease, including dominant intermediate II. Research is ongoing into gene therapy, neurotrophic factors and cell-based treatments.www.elsevier.com+1 Because these are experimental and mostly in clinical trials or animal models, it would be unsafe and misleading to give specific drug names, doses or instructions. Instead, here is the general idea of six research directions:

  1. Gene therapy approaches that try to deliver a healthy copy of the affected gene or silence a harmful extra copy.

  2. Small interfering RNA or antisense oligonucleotides that modulate gene expression in peripheral nerves.

  3. Neurotrophic factors (growth factors) that support survival and regrowth of nerve fibres.

  4. Autologous stem cell transplants designed to support or replace damaged Schwann cells.

  5. Small molecules that improve mitochondrial function or axonal transport in affected neurons.

  6. Combined rehabilitation plus biologic therapies in trials to see if rehabilitation enhances any regenerative effect.

All of these are still under study, and anyone interested should ask their neurologist about ongoing clinical trials, not try unproven “stem cell” products marketed online.


Surgeries (procedures and why they are done)

  1. Foot deformity correction (osteotomy and tendon balancing)
    Many people with CMT develop high-arched feet and clawed toes, which make walking painful and unstable. Orthopedic surgeons can cut and realign bones (osteotomy) and move tendons to balance forces across the foot. The purpose is to create a flatter, more stable foot that fits into shoes and braces better, reducing pain and falls.

  2. Tendon transfer surgery for foot drop
    In tendon transfer, a stronger tendon, such as the posterior tibial tendon, is moved and attached so that it helps lift the front of the foot during walking. The purpose is to improve active dorsiflexion, reduce tripping and sometimes reduce dependence on AFOs. The mechanism is mechanical: redirecting muscle force to replace a function lost by weak muscles.

  3. Joint fusion (arthrodesis) in severe deformity
    When joints are badly deformed and unstable, surgeons may fuse them in a better position. In the ankle or mid-foot, this can reduce pain and create a more plantigrade (flat) foot. The trade-off is loss of motion at that joint, but the goal is to improve overall walking and shoe wear.

  4. Spine surgery for severe scoliosis
    Some people with neuromuscular weakness develop significant curvature of the spine. If scoliosis becomes severe or affects breathing or sitting balance, spinal fusion may be considered. The purpose is to stabilise the spine, prevent further curvature and protect lung function, though the decision is complex and made by a specialist team.

  5. Nerve decompression procedures (for superimposed entrapment)
    CMT can coexist with nerve entrapment syndromes like carpal tunnel syndrome. In those cases, surgical decompression of the nerve at the wrist or other sites can relieve additional compression. The purpose is not to treat CMT itself, but to remove extra pressure that may worsen symptoms and function.


Prevention and risk-reduction strategies

Because CMT is genetic, we cannot “prevent” the disease itself. However, we can reduce secondary problems and complications:

  1. Maintain regular physiotherapy and stretching to prevent contractures.

  2. Use braces, footwear and walking aids as recommended to reduce falls and injuries.

  3. Keep a healthy body weight to lower strain on feet, ankles and knees.

  4. Protect feet from burns, frostbite and cuts, especially when sensation is reduced.

  5. Inspect feet daily for blisters, redness or sores and seek help early.

  6. Avoid smoking, which can reduce blood flow to nerves and tissues.

  7. Limit alcohol, which can damage nerves in high amounts.

  8. Keep vaccinations up to date and treat infections early to avoid serious illness and hospitalisation.

  9. Avoid medicines known to be toxic to peripheral nerves whenever safer alternatives exist, under guidance from your doctor.

  10. Attend regular follow-up appointments so changes are noticed early.


When to see a doctor

You should see a doctor regularly for planned follow-up, but certain changes need urgent review. These include sudden or rapidly worsening weakness, new difficulty breathing or swallowing, new falls, or new bladder or bowel problems. New severe pain, colour change or swelling in a limb, or open sores on the feet also need quick attention. Mood changes, such as persistent sadness or thoughts of harming yourself or others, should be discussed immediately with a trusted adult and a health professional. When in doubt, it is safer to ask your neurologist or primary doctor to review you.


What to eat and what to avoid

For CMT, there is no special “miracle diet,” but a balanced diet helps overall health, muscles and nerves.

  1. Eat plenty of colourful fruits and vegetables for vitamins, minerals and antioxidants.

  2. Choose whole grains like brown rice, oats and whole-wheat bread instead of refined grains.

  3. Include lean protein sources such as fish, poultry, eggs, beans and lentils to support muscles.

  4. Add healthy fats such as olive oil, nuts, seeds and omega-3-rich fish to support cell membranes.

  5. Ensure adequate calcium and vitamin D through dairy or fortified foods (or as advised supplements) for bone strength.

  6. Drink enough water every day to stay hydrated, which helps energy and concentration.

  7. Limit sugary drinks, sweets and ultra-processed snacks that can lead to weight gain and blood sugar spikes.

  8. Avoid heavy alcohol use; in adults, any alcohol should be within safe limits discussed with a doctor, and for teens it should be avoided.

  9. Be careful with extreme diets and very low-calorie plans, which can cause nutrient deficiencies and worsen weakness.

  10. Do not take large doses of vitamins or herbal products without medical advice, because some can actually damage nerves or interact with medicines.


Frequently asked questions

  1. Is Charcot-Marie-Tooth disease dominant intermediate II curable?
    At present, there is no cure for any form of CMT, including dominant intermediate II. Research into gene therapy and other advanced treatments is active, but these are still experimental. Current care focuses on rehabilitation, orthopaedics and pain control to keep you as active and independent as possible.PMC+2Charcot-Marie-Tooth News+2

  2. Can exercise make my CMT worse?
    When well planned with a physiotherapist, gentle low-impact exercise usually helps rather than harms. The key is to avoid heavy resistance and high-impact activities that cause pain or prolonged fatigue. Regular, moderate exercise helps keep joints flexible, muscles working and heart and lungs healthy.

  3. Will I end up in a wheelchair?
    Many people with CMT never need a wheelchair full-time, especially with good bracing, physiotherapy and surgery when appropriate. Some may use a wheelchair or scooter for long distances or on bad days to manage fatigue. Planning early and using aids is a sign of strength and self-care, not failure.

  4. Can I have children, and what is the risk they will have CMT?
    Most people with CMT can have children. Because dominant intermediate forms are usually autosomal dominant, each child has about a 50% chance of inheriting the changed gene. Genetic counselling can explain testing options, pregnancy choices and support for decision-making.MedlinePlus+1

  5. Does CMT affect how long I will live?
    For most people with CMT, life expectancy is near normal. The main challenges involve mobility, pain and function, not life-threatening organ failure. In more severe or very rare subtypes, complications like scoliosis or breathing problems need careful monitoring, but with modern care many people live full lives.

  6. Why is my pain so bad even though my muscles just feel weak?
    Neuropathic pain comes from damaged nerves sending incorrect signals to the brain. It is not always related to how strong the muscle looks. That is why treatments often use nerve-targeting drugs like pregabalin or duloxetine and psychological strategies to help the brain handle pain signals.Charcot-Marie-Tooth Association+1

  7. Are there special shoes I should wear?
    Supportive shoes with firm heel counters, wide toe boxes and good grip are very important. Custom shoes and insoles, prescribed by an orthotist or podiatrist, can accommodate high arches or deformities. The goal is comfort, stability and protection, not fashion, though many people can still find styles they like with professional help.Charcot-Marie-Tooth Association+1

  8. Will surgery fix my CMT?
    Surgery can correct foot shape or spine curvature and relieve pressure on nerves, but it does not cure the underlying genetic problem. It is a tool to improve function, reduce pain and make bracing and shoes more effective. Decisions about surgery are very individual and should involve experienced neuromuscular and orthopedic teams.

  9. Can I take any painkiller I want if my pain is bad?
    No. Some painkillers interact with each other or with other medicines, and high doses can damage organs like the liver, kidneys, heart or brain. Certain drugs, especially opioids or strong sedatives, carry dependence and safety risks. You must always ask your doctor which medicines are safe for you and exactly how to take them.

  10. Are there medicines I should avoid because of CMT?
    Certain chemotherapy drugs and a few antibiotics are known to be toxic to peripheral nerves and may be avoided or used with extra caution in people with CMT. Your neurologist can give you a list or a letter to show other doctors and dentists. Never stop a prescribed medicine suddenly without first discussing it with the prescriber.

  11. Will supplements cure or reverse my CMT?
    Supplements can correct deficiencies and support general health, but they do not change the gene that causes CMT. Taking huge doses of vitamins or “nerve boosters” without medical advice can sometimes do harm, such as high-dose B6 causing neuropathy. Blood tests and professional guidance keep supplement use safe and realistic.

  12. Is it safe to play sports or do PE at school?
    Many young people with CMT can participate in physical education and sports with adaptations. Low-impact activities like swimming or cycling are usually better than contact sports or high-impact running and jumping. It is important to talk with your doctor, physiotherapist, school and family about safe goals and any needed supports.

  13. How can I explain my condition to friends or teachers?
    You can say that you have a genetic condition that affects the nerves to your muscles, making them weaker and affecting your balance and feeling in your feet and hands. It is not contagious, and you did nothing to cause it. Showing a short information sheet from a reliable organisation or your doctor can also help others understand.

  14. What research is happening for CMT?
    Researchers are working on gene therapy, better animal models, biomarkers to track disease, and new drug candidates. Clinical trials test these ideas in volunteers under careful monitoring. Your neurologist or national CMT organisations can tell you about trials and whether you might be eligible, but participation is always voluntary and carefully regulated.Charcot-Marie-Tooth News+2www.elsevier.com+2

  15. What is the most important thing I can do right now?
    The most important steps are to keep regular contact with your neuromuscular team, follow your physiotherapy and orthotic plans, protect your feet and prevent falls, and look after your mental health. Learning about your condition in simple, clear language and asking questions whenever you are unsure will help you feel more in control and better prepared for the future.

Disclaimer: Each person’s journey is unique, treatment planlife stylefood habithormonal conditionimmune systemchronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 31, 2025.

RxHarun
Logo